These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1405942)

  • 1. [A study on reflux esophagitis--clinical nonsense].
    Jaup BH
    Lakartidningen; 1992 Sep; 89(40):3270. PubMed ID: 1405942
    [No Abstract]   [Full Text] [Related]  

  • 2. [Omeprazole is more cost-effective than ranitidine in reflux esophagitis].
    Lindberg G; Jönsson B
    Lakartidningen; 1992 Jul; 89(30-31):2530-3. PubMed ID: 1507987
    [No Abstract]   [Full Text] [Related]  

  • 3. PPIs vs H2RAs for erosive reflux esophagitis.
    King VJ
    J Fam Pract; 1998 Mar; 46(3):199-200. PubMed ID: 9519012
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic factors influencing healing of reflux esophagitis. A controlled trial of omeprazole versus ranitidine. Study group Omega].
    Barbier JP; Haccoun P; Bergmann JF; Arnould B; Hamelin B
    Ann Gastroenterol Hepatol (Paris); 1993; 29(4):213-8. PubMed ID: 8239492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S; Santucci L; Morelli A
    Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of omeprazole and ranitidine in the treatment of reflux esophagitis.
    Blum AL; Riecken EO; Dammann HG; Schiessel R; Lux G; Wienbeck M; Rehner M; Witzel L
    N Engl J Med; 1986 Mar; 314(11):716. PubMed ID: 3513011
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reduced suppression of gastric acid by ranitidine in severe reflux esophagitis. A pilot study].
    Koop H; Klein M; Bauer A; Arnold R
    Z Gastroenterol; 1988 Jul; 26(7):345-50. PubMed ID: 3223004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium].
    Zeitoun P; Rampal P; Barbier P; Isal JP; Eriksson S; Carlsson R
    Gastroenterol Clin Biol; 1989 May; 13(5):457-62. PubMed ID: 2666237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic markers in reflux esophagitis better than wrapped up recommendations].
    Lindberg G; Jönsson B
    Lakartidningen; 1992 Dec; 89(49):4243-4. PubMed ID: 1461046
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Generous treatment with gastric acid blockers. For patients with gastric reflux the proton pump inhibitor power is cost-effective].
    MMW Fortschr Med; 2003 Feb; 145(6):56-7. PubMed ID: 12619364
    [No Abstract]   [Full Text] [Related]  

  • 14. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reflux oesophagitis and its treatment.
    Long RG
    Br J Clin Pract Suppl; 1994; 75():36-9; discussion 40. PubMed ID: 8060800
    [No Abstract]   [Full Text] [Related]  

  • 16. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole versus ranitidine in erosive oesophagitis.
    Zeitoun P; Desjars De Keranroué N; Isal JP
    Lancet; 1987 Sep; 2(8559):621-2. PubMed ID: 2887900
    [No Abstract]   [Full Text] [Related]  

  • 19. [2 or 1 daily doses of ranitidine in the treatment of reflux esophagitis].
    Rohner HG; Wienbeck M
    Z Gastroenterol; 1986 Aug; 24(8):396-402. PubMed ID: 3532593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.